Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension

被引：0

作者：

Wen-Ter Lai

Jeong-Euy Park

Neelesh Dongre

Jackson Wang

机构：

[1] Kaohsiung Medical University Hospital,Division of Cardiology, Department of Internal Medicine

[2] Samsung Medical Center,Cardiology Division

[3] Novartis Pharma AG,Scientific Operations Department, Asia

[4] Novartis (Taiwan) Co.,Pacific, Middle East & African Countries

[5] Ltd.,Scientific Operations Department

来源：

Advances in Therapy | 2011年 / 28卷

关键词：

Asian; combination therapy; efficacy; hypertension; tolerability; valsartan/hydrochlorothiazide single pill;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：427 / 438

页数：11

共 50 条

[1] Efficacy, Safety, and Tolerability of Valsartan/Hydrochlorothiazide in Asian Patients with Essential Hypertension
Lai, Wen-Ter
Park, Jeong-Euy
Dongre, Neelesh
Wang, Jackson
ADVANCES IN THERAPY, 2011, 28 (05) : 427 - 438
[2] Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension
Calhoun, David A.
Glazer, Robert D.
Pettyjohn, Frank S.
Coenen, P. D. M.
Zhao, Yanxing
Grosso, Amie
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (08) : 2303 - 2311
[3] Antihypertensive effects of valsartan/hydrochlorothiazide combination in essential hypertension
Schmidt, A
Adam, SA
Kolloch, R
Weidinger, G
Handrock, R
BLOOD PRESSURE, 2001, 10 (04) : 230 - 237
[4] Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
Ruilope, Luis M.
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1237 - 1248
[5] Efficacy and tolerability of the Valsartan plus Hydrochlorothiazide combination therapy in the treatment of stage I and II essential hypertension: Comparison with amlodipine monotherapy
Kohlmann, O
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 120A - 120A
[6] Efficacy and Tolerability of a Single-Pill Combination of Amlodipine/Valsartan in Asian Hypertensive Patients Not Adequately Controlled with Valsartan Monotherapy
Huang, Jun
Sun, Ning-Ling
Hao, Yu-Ming
Zhu, Jun-Ren
Tu, Yingmei
Curt, Valentin
Zhang, Ying
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2011, 33 (03) : 179 - 186
[7] Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension
Poldermans, Don
Glazer, Robert
Karagiannis, Stefanos
Wernsing, Margaret
Kaczor, Jeanne
Chiang, YannTong
Yen, Joseph
Gamboa, Raul
Fomina, Irina
CLINICAL THERAPEUTICS, 2007, 29 (02) : 279 - 289
[8] Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension
Fogari, Roberto
Mugellini, Amedeo
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2007, 8 (03) : 139 - 144
[9] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
Calhoun, David A.
Crikelair, Nora A.
Yen, Joseph
Glazer, Robert D.
ADVANCES IN THERAPY, 2009, 26 (11) : 1012 - 1023
[10] Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study
El-Etriby, Adel Mohamed Kamal
Rakha, Sameh
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 537 - 544

← 1 2 3 4 5 →